Essure Birth Control Device
- Migration of the device and puncturing of the uterus and/or fallopian tubes, often requiring a second surgery to remove the uterus, fallopian tubes and/or ovaries
- Abdominal and pelvic pain and excessive bleeding
- Allergic reactions, including rashes, hair loss and tooth decay
- Unintended pregnancy
- Unrelenting fatigue
Since its release into the market, the FDA has received more that 26,000 complaints relating to the device. In 2016, the FDA ordered the company to add a “black box” to the label – their most serious warning – to make consumers aware of the risks.
Finally, on July 20, 2018, Bayer has announced that it will stop selling Essure in the United States at the end of this year. Although Bayer had previously announced it would stop selling it outside of the United States, its announcement on July 20 has put an end to the company’s plan to continue selling this incredibly harmful product.
The Food and Drug Administration addressed Bayer’s decision to stop selling Essure. “The device has been associated with serious risks, including persistent pain, perforation of the uterus and fallopian tubes, and migration of the coils into the pelvis or abdomen,” FDA commissioner Scott Gottlieb, M.D. said in a statement last week. “As the FDA learned more from patients about the serious adverse events associated with this device, we took a series of important actions to better understand the benefits and risks, and to address patient safety concerns.”
If you were injured by the Essure Device, you may be eligible for compensation. Our experienced Personal Injury Attorneys are here to review your case in order to determine if you have a valid claim.
If you prefer to contact us via email, please take a moment to fill out the short form below.
6806 Paragon Place, Suite 100
Richmond, VA 23230
Virginia Beach, VA
272 Bendix Road, Suite 350
Virginia Beach, VA 23452
15 S. Main Street, Suite 600
Greenville, SC 29601
500 Virginia Street East, Suite 1190
Charleston, WV 25301